1. Jiang, Chunhui, Liu, Ye, Wen, Siyuan, Xu, Chunjie, Gu, Lei. 2021. In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma. In Pharmacological research, 169, 105644. doi:10.1016/j.phrs.2021.105644. https://pubmed.ncbi.nlm.nih.gov/33940186/
2. Weber, Sarah, Koschade, Sebastian E, Hoffmann, Christopher M, Glimm, Hanno, Ball, Claudia R. 2019. The notch target gene HEYL modulates metastasis forming capacity of colorectal cancer patient-derived spheroid cells in vivo. In BMC cancer, 19, 1181. doi:10.1186/s12885-019-6396-4. https://pubmed.ncbi.nlm.nih.gov/31796022/
3. Fadel, Hewida H, Ahmed, Mohammad Abd El-Rahman, Gharbeya, Kareem Mahamoud, Roushdy, Mohamed N, Almiry, Reda. 2022. Partial-Methylated HeyL Promoter Predicts the Severe Illness in Egyptian COVID-19 Patients. In Disease markers, 2022, 6780710. doi:10.1155/2022/6780710. https://pubmed.ncbi.nlm.nih.gov/35655915/
4. Jalali, Ali, Bassuk, Alexander G, Kan, Lixin, McGuire, Tammy, Kessler, John A. 2011. HeyL promotes neuronal differentiation of neural progenitor cells. In Journal of neuroscience research, 89, 299-309. doi:10.1002/jnr.22562. https://pubmed.ncbi.nlm.nih.gov/21259317/
5. Veithen, Mona, Huyghe, Aurélia, Van Den Ackerveken, Priscilla, Delacroix, Laurence, Malgrange, Brigitte. 2023. Sox9 Inhibits Cochlear Hair Cell Fate by Upregulating Hey1 and HeyL Antagonists of Atoh1. In Cells, 12, . doi:10.3390/cells12172148. https://pubmed.ncbi.nlm.nih.gov/37681879/
智鼠故事 
